Background illustration for clinical trials search

Paid Clinical Trials Calgary

Discover 521 paid clinical trials in Calgary, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors

for
Liver Tumors
Location: Calgary
Sponsor: Alberta Health services

Sex: All

Age: 18+

Code: NCT00691691

Phase 2, Recruiting

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

for
Follicular Lymphoma (FL)
Location: Calgary, Salt Lake City UT, Los Angeles CA, Tucson AZ,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06091254

Phase 3, Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

for
Non-Small-Cell Lung Cancer,
Location: Calgary, Edmonton, Vancouver, Edmonds WA, Aurora CO,
Sponsor: ArriVent BioPharma, Inc.

Sex: All

Age: 18+

Code: NCT07185997

Phase 3, Recruiting

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: Calgary, Edmonton, Los Angeles CA, Gilbert AZ,
Sponsor: AVEO Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06064877

Phase 3, Recruiting

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

for
Cutaneous Melanoma, Stage II
Location: Calgary, Kelowna, Portland OR, Clackamas OR,
Sponsor: Melanoma and Skin Cancer Trials Limited

Sex: All

Age: 18+

Code: NCT03860883

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Early Integration of Palliative and Supportive Care in Cellular Therapy

for
Leukemia, Lymphoma, Multiple Myeloma, Blood Cancer,
Location: Calgary
Sponsor: Alberta Health Services, Calgary

Sex: All

Age: 18+

Code: NCT05190653

Recruiting

APBI: 27Gy in 5 Fractions for Early Breast Cancer

for
Breast Cancer
Location: Calgary
Sponsor: AHS Cancer Control Alberta

Sex: Female

Age: 50+

Code: NCT02681107

Recruiting

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

for
H3 K27M, Glioma
Location: Calgary, Vancouver, London, Toronto, Ottawa, Montreal
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 0+

Code: NCT05580562

Phase 3, Recruiting

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

for
Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor,
Location: Calgary, Los Angeles CA, Iowa City IA, Warrenville IL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 12+

Code: NCT04924075

Phase 2, Recruiting

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

for
Multiple Myeloma
Location: Calgary, Edmonton, Fort Collins CO, Loveland CO,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06057402

Recruiting

SNV1521 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Calgary, West Valley City UT, Toronto, Nashville TN,
Sponsor: Synnovation Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06220864

Phase 1, Recruiting

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer,
Location: Calgary, Edmonton, Vancouver WA, Portland OR,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222566

Phase 3, Recruiting

Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases

for
Cancer Metastatic
Location: Calgary, Vancouver, Windsor, London, Newmarket,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06391242

Phase 3, Recruiting

Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma

for
Non-hodgkin Lymphoma
Location: Calgary, Regina, Vancouver, Hamilton, Toronto, Ottawa,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT05998642

Phase 2, Recruiting

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

for
Endometrial Cancer
Location: Calgary, Edmonton, Kelowna, Prince George, Vancouver,
Sponsor: Canadian Cancer Trials Group

Sex: Female

Age: 18+

Code: NCT05640999

Phase 2, Recruiting

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Calgary, Omaha NE, Rochester MN, Duarte CA, Phoenix AZ,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06121843

Phase 1, Recruiting

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

for
Relapsed or Refractory Multiple Myeloma (RRMM)
Location: Calgary, Vancouver, Salt Lake City UT, Los Angeles CA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06615479

Phase 3, Recruiting

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Calgary, Edmonton, Vancouver, Seattle WA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT05006716

Phase 1, Phase 2, Recruiting

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

for
Oligometastatic Prostate Cancer (OMPC)
Location: Calgary, Springfield OR, Denver CO, San Francisco CA,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT05939414

Phase 3, Recruiting

A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

for
Breast Neoplasm Female, Radiotherapy, Cosmetic Outcome
Location: Calgary, Saskatoon, Victoria, Sault Ste. Marie, Windsor,
Sponsor: Ontario Clinical Oncology Group (OCOG)

Sex: Female

Age: 50 - 70+

Code: NCT05417516

Phase 3, Recruiting